CONMED Corporation  

(Public, NASDAQ:CNMD)   Watch this stock  
Find more results for Robert R. Bent
39.17
-0.13 (-0.33%)
Real-time:   11:12AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 38.92 - 39.69
52 week 30.86 - 50.47
Open 39.48
Vol / Avg. 132,412.00/249,932.00
Mkt cap 1.07B
P/E 31.39
Div/yield 0.20/2.04
EPS 1.25
Shares 27.34M
Beta 1.33
Inst. own 97%
Oct 22, 2014
Q3 2014 Conmed Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Sep 10, 2014
Conmed Corp Annual General Meeting - 3:30PM EDT - Add to calendar
Jul 23, 2014
Q2 2014 CONMED Earnings Release
Jul 23, 2014
Q2 2014 Conmed Corp Earnings Call - Webcast
May 22, 2014
Conmed Corp Annual Shareholder Meeting
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 5.45% 4.71%
Operating margin 8.47% 7.37%
EBITD margin - 15.71%
Return on average assets 3.77% 3.31%
Return on average equity 6.87% 5.92%
Employees 3,600 -
CDP Score - -

Address

525 FRENCH ROAD
UTICA, NY 13502
United States - Map
+1-315-6243215 (Phone)
+1-315-7970321 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

CONMED Corporation (CONMED) is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring. The Company's products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The Company operates in five segments: CONMED Endoscopic Technologies, CONMED Endosurgery, CONMED Electrosurgery, CONMED Linvatec and CONMED Patient Care. The Company offers a range of devices and products for uses in arthroscopic surgery. The Company's powered instruments product line includes the MPower battery system. The Company's patient care product line includes a line of vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, electrocardiogram (ECG) electrodes and cables, cardiac defibrillation and pacing pads and blood pressure cuffs.

Officers and directors

Mark E. Tryniski Independent Chairman of the Board
Age: 53
Bio & Compensation  - Reuters
Curt R. Hartman Interim Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Robert D. Shallish Jr. Chief Financial Officer, Executive Vice President - Finance, IR Contact Officer
Age: 65
Bio & Compensation  - Reuters
Daniel S. Jonas Executive Vice President - Legal Affairs, General Counsel
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Luke A. Pomilio Executive Vice President, Corporate General Manager, Controller
Age: 49
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Heather L. Cohen Executive Vice President - Human Resources, Deputy General Counsel, Secretary
Age: 41
Bio & Compensation  - Reuters
William W. Abraham Executive Vice President - Business Development
Age: 82
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joseph G. Darling Executive Vice President - Commercial Operations
Age: 56
Bio & Compensation  - Reuters
Gregory Renard Jones Executive Vice President - Quality Assurance/Regulatory Affairs
Age: 59
Bio & Compensation  - Reuters
Brian P. Concannon Independent Director
Age: 56
Bio & Compensation  - Reuters